VYNE   $2.47  2.92% Market Open

Vyne Therapeutics Inc
Total Cash 78.10M
totalCashPerShare 5.295
EBITDA
Total Debt 145.00K
quickRatio 6.645
currentRatio 7.127
Total Revenue 486.00K
debtToEquity 0.194
Revenue/Share 0.016
ROA -0.34542
ROE -0.60468
grossProfits
freeCashflow -13.92M
operatingCashflow -26.75M
earningsGrowth
revenueGrowth 0.467
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -52.50505
profitMargins 0.0
enterpriseValue -42.56M
forwardPE -2.7586207
floatShares 10.07M
sharesOutstanding 14.75M
sharesShort 58.19K
sharesShortPriorMonth 46.50K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.56%
Short Ratio help_outline 1.57%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 5.151
Price To Book help_outline 0.47
earningsQuarterlyGrowth
netIncomeToCommon -28.01M
trailingEps 1.72%
forwardEps -0.87%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2024
institutionsCount 38
lastUpdated Oct. 22, 2024, 1:13 p.m.